Machine learning predicts immunoglobulin light chain toxicity through somatic mutations
Garofalo, M.; Piccoli, L.; Ravasio, S.; Foglierini, M.; Matkovic, M.; Sgrignani, J.; Prunotto, M.; Michielin, O.; Lanzavecchia, A.; Cavalli, A.
Show abstract
In systemic light chain amyloidosis (AL), pathogenic monoclonal immunoglobulin light chains (LCs) form toxic aggregates and amyloid fibrils in target organs. Prompt diagnosis is crucial to avoid permanent organ damage. However, delays in diagnosis are common, with a consequent poor patients prognosis, as symptoms usually appear only after strong organ involvement. Here, we present LICTOR, a machine learning approach predicting LC toxicity in AL, based on the distribution of somatic mutations acquired during clonal selection. LICTOR achieved a specificity and a sensitivity of 0.82 and 0.76, respectively, with an area under the receiver operating characteristic curve (AUC) of 0.87. Tested on an independent set of 12 LCs sequences with known clinical phenotypes, LICTOR achieved a prediction accuracy of 83%. Furthermore, we were able to abolish the toxic phenotype of an LC by in silico reverting two germline-specific somatic mutations identified by LICTOR and by experimentally assessing the loss of in vivo toxicity in a Caenorhabditis elegans model. Therefore, LICTOR represents a promising strategy for AL diagnosis and reducing high mortality rates in AL.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Interpretable machine learning identifies paediatric Systemic Lupus Erythematosus subtypes based on gene expression data 93%
- Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning 92%
- Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2 92%
Similar papers in this journal
Similar papers in this journal
- Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidates 93%
- NovumRNA: accurate prediction of non-canonical tumor antigens from RNA sequencing data 92%
- Latent factor modelling of scRNA-seq data uncovers novel pathways dysregulated in cell subsets of autoimmune disease patients 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.